3 Year return

15.32%
20222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Launched on January 2013 (12 years)

Investment Details

₹100

Minimum SIP Amount

₹5000

Minimum one time investment

Fund has no lock-in period

Calculate Returns

Based on past performance of this fund

ENTER AMOUNT

Your Investment ₹3,600
Gain
  • 27.56%
  • ₹992
  • Total Value
  • ₹4,592

Risk Involved

scale

Your principal will be at

Very High Risk

Scheme Information

Asset Under Management

₹7132.82 Cr.

Expense Ratio

0.92% (inclusive of GST)

Exit Load

1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Ratings

ARQ Rating
0

Ratings by other agencies

0
0
0

Tax Implications

Withdrawal within 1 year

Exit load + 15% tax on gains

Withdrawal after 1 year

10% tax on gains over ₹1 Lakh per financial year

Fund Holdings

Holdings
₹7132.82Crores
Other Holdings% of Asset
Dr Reddy's Labs4.78 %
Gland Pharma4.08 %
TREPS3.92 %
J B Chem & Pharm3.7 %
Zydus Lifesci.3.61 %
Abbott India3.2 %
Vijaya Diagnost.3.1 %
Ajanta Pharma3.01 %
Medplus Health3.01 %
Mankind Pharma2.99 %
Aurobindo Pharma2.91 %
Sanofi India2.75 %
Narayana Hrudaya2.71 %
Alkem Lab2.56 %
Glaxosmi. Pharma2.5 %
Torrent Pharma.2.24 %
Pfizer1.9 %
Fortis Health.1.72 %
Thyrocare Tech.1.6 %
Orchid Pharma1.09 %
Syngene Intl.1.09 %
Indoco Remedies0.84 %
Concord Biotech0.59 %
Metropolis Healt0.53 %
Astrazeneca Phar0.48 %
Health.Global0.21 %
Jubilant Pharmo0.07 %
C C I0.02 %
Net CA & Others-0.11 %

Nippon India Mutual Fund Managers

SB

Sailesh Raj Bhan

Fund Manager since May 2018

View Details

Fund House Details

Nippon India Mutual Fund

Nippon India Mutual Fund Asset management company

AUM ₹433,896.92 Cr.
No. of Schemes 293
Setup Date June 1995

Peer Comparison

Comparison with other similar funds

Schemes by Nippon India Mutual Fund

List of mutual fund schemes by AMC

About Nippon India Pharma Fund Direct Plan Growth Plan Growth

Nippon India Pharma Fund Direct Plan Growth Plan Growth is offered by Nippon India Mutual Fund Company. It is an open-ended equity fund that predominantly invests in equity and equity-related securities in large-cap, mid-cap, and small-cap companies. Nippon India Pharma Fund Direct Plan Growth Plan Growth is a sectoral fund that focuses on investing in direct and associated companies in the pharmaceutical sector.

Investment Objective of the Scheme

The fund predominantly seeks to generate consistent returns from investing in companies benefiting directly and indirectly from the pharma and allied sectors in India. It invests in equities across the market capitalisation spectrum. The recommended period to generate returns from the fund is 2-3 years.

Key Features of The Fund

5-year return 25.74%
Expense Ratio 0.92%
Fund Manager Sailesh Raj Bhan
Fund Size ₹7132.82 Cr
Risk Profile Very High

Is This Scheme Right for Me?

The Nippon India Pharma Fund Direct Plan is suitable for investors with advanced knowledge of macroeconomic trends who are ready to take higher risks for higher returns. The fund invests in a concentrated portfolio, which increases the investment risk. Investors investing in the fund may experience losses even when the overall market is positive. If the aim is to generate long-term appreciation from selective exposure to high-risk concentrated portfolios, you may consider investing in Nippon India Pharma Fund Direct. You may determine your risk tolerance level and overall investment goal before investing.

AMC Contact Details

Name Nippon India Mutual Fund
Launch Date June 1995
Addresss Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013
Contact 1860 266 0111
Email customercare@nipponindiaim.in
Website https://mf.nipponindiaim.com/

Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.

Combat Inflation with SIP Investments

Compound growth and steady contributions through SIPs balance the negative effects of inflation, guaranteeing that your money increases faster than inflation. Use Angel One's free SIP calculator online to estimate potential returns and plan your inflation-hedging investment strategy effectively.

FAQs

What is today's NAV of Nippon India Pharma Fund?

NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of Nippon India Pharma Fund on May 29 2024, is ₹482.0148